119 related articles for article (PubMed ID: 20888411)
1. Codrug: an efficient approach for drug optimization.
Das N; Dhanawat M; Dash B; Nagarwal RC; Shrivastava SK
Eur J Pharm Sci; 2010 Dec; 41(5):571-88. PubMed ID: 20888411
[TBL] [Abstract][Full Text] [Related]
2. Prodrugs: design and clinical applications.
Rautio J; Kumpulainen H; Heimbach T; Oliyai R; Oh D; Järvinen T; Savolainen J
Nat Rev Drug Discov; 2008 Mar; 7(3):255-70. PubMed ID: 18219308
[TBL] [Abstract][Full Text] [Related]
3. What should be considered on design of a colon-specific prodrug?
Jung Y; Kim YM
Expert Opin Drug Deliv; 2010 Feb; 7(2):245-58. PubMed ID: 20095945
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in prodrugs as drug delivery systems.
Lin C; Sunkara G; Cannon JB; Ranade V
Am J Ther; 2012 Jan; 19(1):33-43. PubMed ID: 21150770
[TBL] [Abstract][Full Text] [Related]
5. Flurbiprofen derivatives in Alzheimer's disease: synthesis, pharmacokinetic and biological assessment of lipoamino acid prodrugs.
Pignatello R; Pantò V; Salmaso S; Bersani S; Pistarà V; Kepe V; Barrio JR; Puglisi G
Bioconjug Chem; 2008 Jan; 19(1):349-57. PubMed ID: 18072715
[TBL] [Abstract][Full Text] [Related]
6. Phase I and phase II ocular metabolic activities and the role of metabolism in ophthalmic prodrug and codrug design and delivery.
Al-Ghananeem AM; Crooks PA
Molecules; 2007 Mar; 12(3):373-88. PubMed ID: 17851396
[TBL] [Abstract][Full Text] [Related]
7. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
[TBL] [Abstract][Full Text] [Related]
8. Design of self-immolative linkers for tumour-activated prodrug therapy.
Tranoy-Opalinski I; Fernandes A; Thomas M; Gesson JP; Papot S
Anticancer Agents Med Chem; 2008 Aug; 8(6):618-37. PubMed ID: 18690826
[TBL] [Abstract][Full Text] [Related]
9. Targeting the delivery of glycan-based paclitaxel prodrugs to cancer cells via glucose transporters.
Lin YS; Tungpradit R; Sinchaikul S; An FM; Liu DZ; Phutrakul S; Chen ST
J Med Chem; 2008 Dec; 51(23):7428-41. PubMed ID: 19053781
[TBL] [Abstract][Full Text] [Related]
10. Membrane transporter/receptor-targeted prodrug design: strategies for human and veterinary drug development.
Majumdar S; Duvvuri S; Mitra AK
Adv Drug Deliv Rev; 2004 Jun; 56(10):1437-52. PubMed ID: 15191791
[TBL] [Abstract][Full Text] [Related]
11. Buccal bioadhesive drug delivery--a promising option for orally less efficient drugs.
Sudhakar Y; Kuotsu K; Bandyopadhyay AK
J Control Release; 2006 Aug; 114(1):15-40. PubMed ID: 16828915
[TBL] [Abstract][Full Text] [Related]
12. [Research of oral prodrugs: opportunities and challenges].
Cao F; Ping QN; Chen J
Yao Xue Xue Bao; 2008 Apr; 43(4):343-9. PubMed ID: 18664193
[TBL] [Abstract][Full Text] [Related]
13. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
14. Pharmaceutical approaches to colon targeted drug delivery systems.
Chourasia MK; Jain SK
J Pharm Pharm Sci; 2003; 6(1):33-66. PubMed ID: 12753729
[TBL] [Abstract][Full Text] [Related]
15. Designing for topical delivery: prodrugs can make the difference.
Sloan KB; Wasdo S
Med Res Rev; 2003 Nov; 23(6):763-93. PubMed ID: 12939791
[TBL] [Abstract][Full Text] [Related]
16. The codrug approach for facilitating drug delivery and bioactivity.
Aljuffali IA; Lin CF; Chen CH; Fang JY
Expert Opin Drug Deliv; 2016 Sep; 13(9):1311-25. PubMed ID: 27159251
[TBL] [Abstract][Full Text] [Related]
17. Scope and limitations of the co-drug approach to topical drug delivery.
Lau WM; White AW; Gallagher SJ; Donaldson M; McNaughton G; Heard CM
Curr Pharm Des; 2008; 14(8):794-802. PubMed ID: 18393881
[TBL] [Abstract][Full Text] [Related]
18. Alkyl ester prodrugs for improved topical delivery of ibuprofen.
Bansal AK; Khar RK; Dubey R; Sharma AK
Indian J Exp Biol; 2001 Mar; 39(3):280-3. PubMed ID: 11495290
[TBL] [Abstract][Full Text] [Related]
19. Heparin-paclitaxel conjugates as drug delivery system: synthesis, self-assembly property, drug release, and antitumor activity.
Wang Y; Xin D; Liu K; Zhu M; Xiang J
Bioconjug Chem; 2009 Dec; 20(12):2214-21. PubMed ID: 19950889
[TBL] [Abstract][Full Text] [Related]
20. PSA-specific and non-PSA-specific conversion of a PSA-targeted peptide conjugate of doxorubicin to its active metabolites.
Wong BK; DeFeo-Jones D; Jones RE; Garsky VM; Feng DM; Oliff A; Chiba M; Ellis JD; Lin JH
Drug Metab Dispos; 2001 Mar; 29(3):313-8. PubMed ID: 11181501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
